BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18435811)

  • 1. Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?
    Burger M; Denzinger S; Wieland WF; Stief CG; Hartmann A; Zaak D
    BJU Int; 2008 Jul; 102(2):194-7. PubMed ID: 18435811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
    Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
    Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
    J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
    Bertz S; Denzinger S; Otto W; Wieland WF; Stoehr R; Hofstaedter F; Hartmann A
    Histopathology; 2011 Oct; 59(4):722-32. PubMed ID: 22014053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of grading of urothelial carcinoma in transurethral resection of urinary bladder tumor specimens.
    Desai F; Singh NJ; Jetly D; Shah M
    Indian J Pathol Microbiol; 2007 Apr; 50(2):293-5. PubMed ID: 17883048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grading of noninvasive papillary urothelial neoplasms.
    MacLennan GT; Kirkali Z; Cheng L
    Eur Urol; 2007 Apr; 51(4):889-97; discussion 897-8. PubMed ID: 17095142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.
    Kapur U; Antic T; Venkataraman G; Durazo-Arvizu R; Quek MM; Flanigan RC; Wojcik EM
    Urology; 2007 Nov; 70(5):1028-33. PubMed ID: 18068480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors.
    Pellucchi F; Freschi M; Ibrahim B; Rocchini L; Maccagnano C; Briganti A; Rigatti P; Montorsi F; Colombo R
    J Urol; 2011 Dec; 186(6):2194-9. PubMed ID: 22019037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    J Clin Pathol; 2010 Oct; 63(10):910-5. PubMed ID: 20876324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.